Holding(s) in Company
11 Februar 2009 - 11:45AM
UK Regulatory
TIDMCUR
RNS Number : 1442N
Curidium Medica PLC
11 February 2009
Form TR-1 with annex. FSA Version 2.1 updated April 2007
+-----------------------------------------------------------------------------+
| TR-1: Notifications of Major Interests in Shares |
+-----------------------------------------------------------------------------+
+----------------------------------------+---------------+---------------+----------+
| 1. Identity of the issuer or the underlying issuer of | Curidium Medica plc |
| existing shares to which voting rights are attached: | |
+--------------------------------------------------------+--------------------------+
| 2. Reason for notification (yes/no) |
+-----------------------------------------------------------------------------------+
| An acquisition or disposal of voting rights | Yes |
+------------------------------------------------------------------------+----------+
| An acquisition or disposal of financial instruments which may result | No |
| in the acquisition of shares already issued to which voting rights are | |
| attached | |
+------------------------------------------------------------------------+----------+
| An event changing the breakdown of voting rights | No |
+------------------------------------------------------------------------+----------+
| Other (please specify): | No |
+------------------------------------------------------------------------+----------+
| 3. Full name of person(s) subject to | Gartmore Investment Limited |
| notification obligation: | |
+----------------------------------------+------------------------------------------+
| 4. Full name of shareholder(s) (if | See attached schedule |
| different from 3): | |
+----------------------------------------+------------------------------------------+
| 5. Date of transaction (and date on | 3 February 2009 |
| which the threshold is crossed or | |
| reached if different): | |
+----------------------------------------+------------------------------------------+
| 6. Date on which issuer notified: | 4 February 2009 |
+----------------------------------------+------------------------------------------+
| 7. Threshold(s) that is/are crossed or | 19% |
| reached: | |
+----------------------------------------+---------------+---------------+----------+
+---------------+---------------+-----------+-----------+---------------+-----------+---------+----------+
| 8: Notified Details |
+--------------------------------------------------------------------------------------------------------+
| A: Voting rights attached to shares |
| |
+--------------------------------------------------------------------------------------------------------+
| Class/type of | Situation | Resulting situation after the triggering |
| shares | previous to the | transaction |
| If possible | triggering | |
| use ISIN code | transaction | |
+ +---------------------------+------------------------------------------------------------+
| | Number of | Number | Number | Number of voting | Percentage of |
| | shares | of | of | rights | voting rights |
| | | voting | shares | | |
| | | rights | | | |
+ + + + +---------------------------+--------------------+
| | | | | Direct | Indirect | Direct | Indirect |
+---------------+---------------+-----------+-----------+---------------+-----------+---------+----------+
| GB00B2PNRV79 | 3,805,999 | 3,805,999 | 3,727,682 | | 3,727,682 | | 19.68% |
+---------------+---------------+-----------+-----------+---------------+-----------+---------+----------+
+---------------+---------------+---------------+----------------------+---------------+
| B: Financial Instruments |
| |
+--------------------------------------------------------------------------------------+
| Resulting situation after the triggering transaction |
| |
+--------------------------------------------------------------------------------------+
| Type of | Expiration | Exercise/ | No. of voting | Percentage of |
| financial | date | conversion | rights that | voting rights |
| instrument | | period/date | may be | |
| | | | acquired (if | |
| | | | the | |
| | | | instrument | |
| | | | exercised/converted) | |
+---------------+---------------+---------------+----------------------+---------------+
| N/A | N/A | N/A | N/A | N/A |
| | | | | |
+---------------+---------------+---------------+----------------------+---------------+
+--------------------------------------+--------------------------------------+
| Total (A+B) |
| |
+-----------------------------------------------------------------------------+
| Number of voting rights | Percentage of voting rights |
+--------------------------------------+--------------------------------------+
| 3,727,682 | 19.68% |
+--------------------------------------+--------------------------------------+
+-----------------------------------------------------------------------------+
| 9. Chain of controlled undertakings through which the voting rights and /or |
| the financial instruments are effectively held, if applicable: |
+-----------------------------------------------------------------------------+
| N/A |
| |
+-----------------------------------------------------------------------------+
+--------------------------------------+--------------------------------------+
| Proxy Voting: |
| |
+-----------------------------------------------------------------------------+
| 10. Name of proxy holder: | N/A |
| | |
+--------------------------------------+--------------------------------------+
| 11. Number of voting rights proxy | N/A |
| holder will cease to hold: | |
| | |
+--------------------------------------+--------------------------------------+
| 12. Date on which proxy holder will | N/A |
| cease to hold voting rights: | |
| | |
+--------------------------------------+--------------------------------------+
+--------------------------------------+--------------------------------------+
| 13. Additional information: | All shares are held indirectly. |
| | |
+--------------------------------------+--------------------------------------+
| 14 Contact name: | Robert Smith, Curidium Medica Plc |
| | |
+--------------------------------------+--------------------------------------+
| 15. Contact telephone name: | 020 7383 5345 |
| | |
+--------------------------------------+--------------------------------------+
For notes on how to complete form TR-1 please see the FSA website.
Schedule
+-------------+-------------+-------------+-------------+-------------+-------------+
| Fund | No. of | Percentage | UK | Fund | Beneficial |
| managing co | shares held | of issued | Registered | | Owner |
| | (Ord GBP | share | owner | | |
| | 0.03) | capital | | | |
+-------------+-------------+-------------+-------------+-------------+-------------+
| Gartmore | 1,179,699 | 6.227% | HSBC Global | 56690 | Gartmore |
| Fund | | | Custody | | Fund |
| Managers | | | Nominee UK | | Managers |
| Limited | | | Ltd | | Ltd a/c |
| | | | | | Gartmore UK |
| | | | | | & Irish |
| | | | | | Smaller |
| | | | | | Companies |
+-------------+-------------+-------------+-------------+-------------+-------------+
| Gartmore | 380,540 | 2.009% | Gartmore | LST | Gartmore |
| Investment | | | Smaller | | Smaller |
| Limited | | | Companies | | Companies |
| | | | Trust Plc | | Trust PLC |
+-------------+-------------+-------------+-------------+-------------+-------------+
| Gartmore | 41,143 | 0.217% | Gartmore Co | 56630 | Gartmore Co |
| Investment | | | Dealing | | Dealing |
| Limited | | | Limited | | Limited |
+-------------+-------------+-------------+-------------+-------------+-------------+
| Gartmore | 976,220 | 5.153% | Vidacos | Volant | The |
| Investment | | | Nominees | | Alphagen |
| Limited | | | Ltd a/c | | Volantis |
| | | | 2303 | | Fund |
| | | | | | Limited |
+-------------+-------------+-------------+-------------+-------------+-------------+
| Gartmore | 1,150,080 | 6.071% | Nortrust | 54550 | Strathclyde |
| Investment | | | Nominees | | Pension |
| Limited | | | Limited | | Fund |
+-------------+-------------+-------------+-------------+-------------+-------------+
| | 3,727,682 | 19.678% | | | |
| TOTAL | | | | | |
| HOLDING | | | | | |
+-------------+-------------+-------------+-------------+-------------+-------------+
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLTBMMTMMIBBJL
Curidium Medica (LSE:CUR)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
Curidium Medica (LSE:CUR)
Historical Stock Chart
Von Jun 2023 bis Jun 2024
Echtzeit-Nachrichten über Curidium Medica (Londoner Börse): 0 Nachrichtenartikel
Weitere Curidium Medica Plc News-Artikel